68Ga-HER2 affibody PET/CT indicates a high accuracy in the detection of converted HER2 expression in metastatic cancer, which may assist in anti-HER2 treatment modification during patient management (20, 21). Here, ERBB2 is linked to metastatic malignant neoplasm.